2025年，全国多个小区物业都出现了降价潮！ 例如：武汉东湖朗诗里程小区，物业费从每平米2.5元降到1.1元；武汉江山如画八期，物业费由3元每平降至1.6元每平，降幅惊人；武汉中海光谷锦城小 区，业委会成立后，中海物业为了续聘，主动宣布降低物业费，由3.3元每平降至2.6元每平。 成都高新区南城都汇，物费从4元每平调整至3元每平；成华区信合御龙山二期，物业费从4.8元每平降至3.5元每平，降了27%；成都绿地锦都小区，在业 委会成立后，将物业费从3.2元每平调整为2.81元每平。 另一个问题就是收缴率，据数据，当前物业费全国平均收缴率约70%，但近年呈持续下降状态（部分小区通过提升服务或社区治理可大幅改善）。 而这些差价，必须也只能由物业公司来买单，而物业公司，又将压力转移到了员工身上。 另一方面，也代表物业躺着赚钱的时代已经结束了，随之而来的，就是物业公司的欠薪和裁员潮。 首当其冲的就是碧桂园，据数据，碧桂园服务近两年减员超20000人，央企中海物业一年减员近4400人，保利物业减员3700人......整个行业在2024年共减员 5.4万人。 其实减员的原因，说白了就是企业缺钱养不起人了，这也不仅仅是物业 ...

ST柯利达（603828）最新公告筹划控制权变更，公司股票自2026年1月5日起停牌。公司股价2025年累计涨幅达189%。 | 间统计 | 不复权 · 显示停牌 | 到价提醒 等码 | | | ST柯利达 | | 8.38 | -0.24 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 设置均线。 | | 603828 | | | -2.78% | | | | | | | 已收市 CNY | | | 日洗+ | | | | | | | 委比 | -16.24% 委差 | | -237 | | | | | | 8.80 | 英I | 8.44 | 121 | | | | | 8 80 | | | 卖四 | 8.43 | 130 | | | | | | | 7.80 | 第二 | 8.41 | 5 | | | | | | | | | 8.40 | 325 | | | | | | | 670 | | 8.39 | 267 | | | | | | | 5.79 | 奖—— | 8.38 8.36 | 185 60 | | | | | ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 信本股民索赔团队提醒，长园集团已被立案调查，因此受损的投资者，可通过"新浪股民维权平台"自愿 登记索赔。 维权条件： 长园集团：根据相关司法解释，符合以下条件的投资者可发起索赔：于2023年10月28日-2025年4月28日 期间买入且有持仓，无论在2025年4月29日及之后是否卖出。（注：具体赔付范围由法院最终确定） （长园集团维权入口） （本文由上海市信本律师事务所合伙人赵敬国律师供稿，不代表新浪财经的观点。赵敬国律师，于1999 年取得律师资格，法学理论知识扎实，曾在高校任教。20 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 山东证监局拟对朗进科技及相关责任人开出了总计1015万元的罚单，并予以警告。 这张罚单详细分解来看，朗进科技被处以250万元罚款。实控人李敬茂不仅明知资金占用事项却决策不 予披露，还利用实际控制人地位 "组织、指使" 了这起违规行为。因此实际控制人李敬茂的责任最为严 重，被处以440万元罚款，其余4名责任人同样被罚款。此外，公司在公告中称违规事项不触及退市红 线。 这起违规事件的时间线显示出监管部门的持续关注。 早在2025年8月27日，朗进科技及实际控制人之一李敬茂就因涉嫌信息披露违法违规被证监会立案。当 月，朗进科技刚披露上半年净利润扭亏为盈的喜讯，同期营业收入却同比下降了10.88%。 资金占用超4亿 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 在董事长决策不予披露的内部指令下，朗进科技（维权）的4.15亿元资金被控股股东悄然占用，而那些 在虚假报告上签字的公司高管，也一同收到了监管开 ...

12月1日晚间，上交所一纸终止上市决定，为*ST苏吴（600200.SH）25年的A股生涯画上句号。 公告显示，根据安排，该公司股票将于12月9日进入退市整理期，期限15个交易日，预计最后交易日为12月29日。退市后，该公司股票拟转入全国 中小企业股份转让系统。 从"普教第一股"到医美概念龙头，*ST苏吴在钱氏姐弟入主后，四年间虚增营业收入超17亿元，一度被占用资金占净资产比例超96%，近乎被"掏 空"。而在钱氏姐弟及相关责任人遭受处罚后，*ST苏吴仍难逃退市命运。 截至12月3日，这家老牌上市公司年内股价跌幅近九成，市值已缩水至8.8亿元左右。该公司股票于11月26日起停牌，但在停牌前5个交易日，公司 还连续获5个涨停。从股东户数来看，截至三季度末，*ST苏吴仍有6.74万名股东。对于已被掏空的*ST苏吴而言，投资者最终能获得多少赔偿， 仍存在不确定性。 △ 图源：图虫 12月3日，时代周报记者致电*ST苏吴证券部，该部门工作人员表示，公司目前生产经营状况正常，当前重点工作是完成最后的退市整理程序，随 后按照交易所和证监会的要求在新三板挂牌。 01 实控人的"影子"游戏 *ST苏吴败走A股市场，绕不开钱氏姐 ...

来源：新华日报 四年累计虚增收入超17亿元，苏州老牌上市公司被强制退市。 12月1日晚间，江苏吴中医药发展股份有限公司（简称"江苏吴中"）披露，上海证券交易所决定终止其 股票上市，公司股票自12月9日起进入为期15个交易日的退市整理期。 此前11月25日，江苏吴中及相关当事人收到中国证监会出具的《行政处罚决定书》。 来源： "江苏吴中"微信公众号 江苏吴中被强制退市 停牌前上演"五连板" 实控人被禁市十年 之所以被强制退市，是因为江苏吴中触及重大违法强制退市情形。 今年2月26日，江苏吴中因涉嫌信息披露违法违规收到中国证监会《立案告知书》。11月25日，江苏吴 中及相关当事人收到中国证监会出具的《行政处罚决定书》，认定其存在隐瞒实控人变更、严重财务造 假、隐瞒资金占用三大问题。 经查明，2018年2月，江苏吴中控股股东苏州吴中投资控股有限公司发生股权变更，变更后，钱群山实 际支配江苏吴中行为，成为江苏吴中实际控制人。但江苏吴中在2018年至2023年的年度报告中，均披露 钱群英为实际控制人。公开资料显示，钱群英与钱群山系姐弟关系，分别出生于1968年、1973年，钱群 英为中专学历。 据江苏吴中最新公告，12 ...

Core Viewpoint - Tianfeng Securities is under investigation by the China Securities Regulatory Commission (CSRC) for alleged violations related to information disclosure and financing, primarily linked to historical issues with its former major shareholder, the Contemporary Group [2][3][4]. Group 1: Investigation and Historical Issues - The CSRC issued a notice on November 28, 2025, indicating that Tianfeng Securities is being investigated for suspected violations of information disclosure and financing laws [2]. - The investigation is believed to be related to historical issues from before 2023, particularly concerning the financial dealings with the former major shareholder, Contemporary Group [2][4]. - Despite the investigation, Tianfeng Securities claims that its current operations are normal and that it will cooperate fully with the CSRC [2]. Group 2: Financial Transactions and Shareholder Changes - The investigation may be associated with the financial transactions disclosed in Tianfeng Securities' 2022 annual report, where it was revealed that the former major shareholder, Wuhan Contemporary Technology Industry Group, had occupied company funds through third parties [3][4]. - From 2020 to 2022, the total payments made by the former major shareholder amounted to 14.75 billion yuan, with a total repayment of 19.03 billion yuan in 2022 alone [4]. - Following the debt crisis of Contemporary Group in 2022, Tianfeng Securities underwent a change in major shareholders, with Hongtai Group becoming the controlling shareholder [7]. Group 3: Financial Performance - After the transition to Hongtai Group's control, Tianfeng Securities experienced significant fluctuations in its financial performance, with a notable recovery in 2025 [9]. - In 2023, the company reported a revenue increase of over 90% to 3.427 billion yuan, and a net profit of 307 million yuan, a substantial improvement from the previous year's loss of over 1.5 billion yuan [9]. - However, in 2024, the company faced a revenue decline of over 20% and a net profit drop of 109.67%, indicating ongoing volatility [9]. Group 4: Capital Increase and Future Outlook - In June 2025, Tianfeng Securities completed a private placement of 1.476 billion shares to Hongtai Group, raising 4 billion yuan for capital enhancement and debt repayment [10]. - The company aims to utilize the raised funds to improve its capital structure and operational liquidity, which is expected to enhance its asset quality [10]. - As of the first three quarters of 2025, Tianfeng Securities ranked 37th in terms of revenue among listed brokerages, although its net profit ranking remains relatively low [10].

Core Points - After nearly six months of investigation, Jiaying Pharmaceutical received a total fine of 4.9 million yuan for information disclosure violations, along with warnings and regulatory actions from the Guangdong Securities Regulatory Bureau and the Shenzhen Stock Exchange [2][5][9] Group 1: Administrative Penalties - The Guangdong Securities Regulatory Bureau issued an administrative penalty decision, imposing a fine of 1.5 million yuan on Jiaying Pharmaceutical, and additional fines on key executives: 1.6 million yuan on Chairman Li Neng, 1 million yuan on General Manager You Yongping, and 800,000 yuan on former CFO Shi Junping, totaling 4.9 million yuan [5][8] - Warnings and regulatory letters were issued to Jiaying Pharmaceutical and its executives, including Li Neng, You Yongping, Shi Junping, and former board secretary Xiao Qiaoxia [5][9] Group 2: Violations and Findings - The investigation revealed that Li Neng, as the actual controller of Hunan Yaojun Pharmaceutical Co., engaged in improper fund transfers between Jiaying Pharmaceutical and its related party, resulting in a total of approximately 220 million yuan in transactions, which accounted for 28.83% of Jiaying Pharmaceutical's latest audited net assets [7][8] - Jiaying Pharmaceutical failed to disclose related party transactions in a timely manner, including transactions with Gonghe Pharmaceutical, which involved approximately 8.76 million yuan, representing 1.15% of the company's latest audited net assets [7][8] Group 3: Additional Regulatory Actions - The Shenzhen Stock Exchange issued a public reprimand against Jiaying Pharmaceutical and its executives, citing violations related to non-operating fund transfers and improper financial assistance [12][13] - Jiaying Pharmaceutical provided a total of 65 million yuan in financial assistance to three non-related companies, with a maximum daily balance of 40 million yuan, which accounted for 5.24% of the company's latest audited net assets [12]

Core Viewpoint - The actual controller of Nanwei Co., Ltd. (603880.SH), Li Ping, sold shares worth 47.96 million yuan to avoid losses exceeding 11 million yuan after learning about a negative internal control report from the accounting firm, leading to severe penalties from the China Securities Regulatory Commission (CSRC) for insider trading [1][2][3]. Group 1: Insider Trading Incident - Li Ping and former financial director Xiang Qinhua received administrative penalties from the Jiangsu Regulatory Bureau of the CSRC for insider trading, with Li Ping facing a total penalty of over 47.1 million yuan and Xiang Qinhua approximately 1.6 million yuan [1][2]. - The insider trading occurred during a sensitive period from March 1 to April 28, 2023, when the company was aware of significant issues regarding fund occupation [2][3]. - Li Ping sold 8.184 million shares between March 14 and 28, 2023, while Xiang Qinhua sold 54,000 shares on March 21 and 22, both actions deemed violations of the Securities Law [2][3]. Group 2: Company Performance and Financials - Nanwei Co., Ltd. has faced increasing losses since 2022, with revenues of 5.45 billion yuan in 2022, 6 billion yuan in 2023, and projected 6.03 billion yuan in 2024, while net profits were -14.65 million yuan, -147 million yuan, and -191 million yuan respectively [4]. - The company attributed the projected losses in 2024 to intense competition in the nitrile glove industry, declining product prices, and rising raw material costs, particularly for nitrile latex [4].

Core Viewpoint - Northern Rare Earth (600111.SH) received a warning letter from the Inner Mongolia Securities Regulatory Bureau for failing to timely disclose non-operating fund occupation by related parties, which has been recorded in the integrity file of the securities and futures market [2][3] Group 1: Regulatory Actions - The warning was issued due to Northern Rare Earth's failure to disclose non-operating fund occupation by its subsidiary, Baogang Energy Conservation and Environmental Protection Technology Co., Ltd., totaling 8.9485 million yuan from February 2019 to December 2024 [2][3] - The regulatory body found that the company violated multiple regulations, including the "Notice on Regulating Fund Transactions with Related Parties" and the "Management Measures for Information Disclosure of Listed Companies" [3] Group 2: Company Response - Northern Rare Earth expressed that it takes the warning seriously and will enhance internal management and improve information disclosure quality to prevent similar incidents in the future [4] - The company emphasized that the administrative regulatory measures will not affect its normal business operations and will submit a written report to the Inner Mongolia Securities Regulatory Bureau as required [4] Group 3: Financial Performance - For the first three quarters of 2025, Northern Rare Earth expects a net profit attributable to shareholders of 1.51 billion to 1.57 billion yuan, representing an increase of 272.54% to 287.34% compared to 405 million yuan in the same period last year [5] - The growth in performance is attributed to the company's strategic market initiatives, production optimization, and cost reduction in rare earth processing [5][6] - The company reported significant increases in the production and sales of its main products, including rare earth metals and functional materials, alongside advancements in project construction and research innovation [6]